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Abstract: Many investments have been made to help address the rising prevalence 
and associated costs of diabetes, but there has been minimal evaluation to assess their 
value. A comprehensive literature review and fi ve expert committee meetings were 
conducted to iteratively conceptualize and develop a Diabetes Evaluation Framework 
(DEFINE). Building on existing frameworks, DEFINE provides an evidence-based 
approach for evaluating diabetes. Th e framework is focused on guiding evaluation, 
building robust evidence, and fostering knowledge translation. DEFINE promotes 
comprehensive evaluation of initiatives targeting diabetes prevention and manage-
ment, and will facilitate policy innovations to reduce the burden of diabetes.
Keywords: chronic disease, complex interventions, diabetes, evaluation, health 
services research, quality improvement
Résumé : Plusieurs investissements ont été déployés pour lutter contre la préva-
lence croissante du diabète et ses coûts aff érents, mais peu d’eff orts  pour évaluer 
leurs bénéfi ces. Une recension exhaustive de la littérature et cinq réunions d’un 
comité d’experts ont eu lieu pour concevoir et développer de façon itérative un cadre 
d’évaluation du diabète. Baptisé DEFINE, ce cadre basé sur des modèles existants 
s’avère une méthode fondée sur des données probantes pour évaluer le diabète. Le 
cadre vise à orienter l’évaluation, établir des données probantes, et faciliter le trans-
fert de connaissances. DEFINE vise la promotion de l’évaluation compréhensive des 
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initiatives ciblant la prévention et la gestion du diabète et facilite les innovations 
politiques aidant à réduire le fardeau du diabète.
Mots clés : maladies chroniques, interventions complexes, diabète, évaluation, re-
cherche sur les services de santé, amélioration de la qualité
Recent projections by the World Health Organization suggest that in 2030 chronic 
diseases will be the leading cause of death globally accounting for approximately 
three quarters of all deaths (World Health Organization, 2008). Chronic diseases 
are among the most preventable of all health problems, yet a recent report for 
Canada estimates that 4.2 million Canadians will develop diabetes by 2020, one 
of the most common of chronic diseases (Canadian Diabetes Association, 2011). 
Th e Public Health Agency of Canada estimated that 58% of total healthcare 
spending in Canada in 2010, totalling $190 billion,1 was attributable to chronic 
diseases, including $68 billion in direct healthcare costs and $122 billion in indi-
rect socioeconomic costs related to decreased productivity (Public Health Agency 
of Canada, 2011b). Specifi c to diabetes, the cost to the healthcare system and 
economy was $11.7 billion in 2010 and was projected to increase to $16 billion by 
2020, not including out-of-pocket costs for patients (e.g., medications, devices, 
supplies, various programs/services) (Canadian Diabetes Association, 2011). 
However, given the fact that one million people are estimated to have undiagnosed 
diabetes (Canadian Diabetes Association, 2011) and the challenges in estimating 
both direct and indirect healthcare costs, it is suspected that the real economic 
burden of diabetes is greater.
To help address the growing diabetes burden, government investment has 
been signifi cant over the past decade. In 1999, the federal Public Health Agency 
of Canada pledged $115 million over fi ve years to develop a Canadian Diabetes 
Strategy (Public Health Agency of Canada, 2011a; Public Health Agency of Can-
ada, 2012), which was renewed at $18 million per year starting in 2005. Th is was 
followed by provincial and territorial initiatives, such as the $741 million in 2008 
for a four-year Ontario Diabetes Strategy (Ministry of Health and Long-Term 
Care, 2008) and the $2.5 million in the fi rst year of a four-year Comprehensive 
Diabetes Strategy for New Brunswick in 2011, which was expanded to $4.7 million 
in 2014 (Canadian Diabetes Association, 2014). To date, no substantive evidence 
exists to demonstrate whether government investments have helped to manage 
the increasing prevalence and burden of diabetes (Offi  ce of the Auditor General 
of Canada, 2013; Offi  ce of the Auditor General of Ontario, 2012).
Th e diabetes-specifi c investments highlighted above have paralleled existing 
government funding (e.g., $335 million for health-promotion programs) (Offi  ce 
of the Auditor General of Canada, 2013) and extensive primary healthcare reform 
strategies to improve healthcare delivery and the health of the population (e.g., 
new funding formulas with salary support for team-based care, fi nancial bonuses 
for chronic disease prevention and surveillance, and support for widespread 
use of electronic medical records (Glazier, Kopp, Schultz, Kiran, & Henry, 2012; 
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Hutchison, Levesque, Strumpf, & Coyle, 2011). Unfortunately, the implementa-
tion of reform strategies resulted in substantial turmoil and confusion both at the 
operational level of clinics and at the policy planning level. Th erefore, notwith-
standing the shortage of evidence to support quality improvement initiatives in 
healthcare, governments and other agencies have funded and launched initiatives 
to support transitions to the new healthcare strategies (Jones & Piterman, 2008; 
Schouten, Hulscher, van Everdingen, Huijsman, & Grol, 2008). Comprehensive 
evaluation of these complex initiatives to determine their impact on intended 
intermediate and long-term outcomes rarely occurs and should be prioritized 
(Crabtree et al., 2011; Craig et al., 2013; Dubois et al., 2011; Glazier et al., 2012; 
Schouten et al., 2008; Tricco et al., 2012; Zimmerman et al., 2011).
RATIONALE FOR A COMPREHENSIVE DIABETES 
EVALUATION FRAMEWORK
To date, no single framework exists to systematically guide the comprehensive 
evaluation of diabetes prevention and management strategies (Borgermans et al., 
2008). With the increasing pandemic of diabetes, rising costs of managing patients 
with diabetes, and new fi scal restraints, such a framework is needed to assess 
the value of investments and guide future spending. A framework to help guide 
the comprehensive and systematic evaluation of programs is critical to under-
stand the multitude of mechanisms and processes underlying care and to provide 
healthcare decision makers and stakeholders with appropriate information about 
the state of their healthcare system (Dubois et al., 2011; Nasmith et al., 2010). 
Otherwise, previously endorsed chronic disease management initiatives that have 
been unable to demonstrate a positive health and economic impact may be at risk 
of losing their funding. A growing consensus in the literature refl ects the urgent 
need for standardized and rigorous comprehensive evaluation (Borgermans et al., 
2008; Crabtree et al., 2011).
AIM
Our aim was to develop a diabetes evaluation framework to guide the compre-
hensive evaluation of initiatives targeting diabetes prevention and management, 
and to facilitate policy innovations to reduce the fi nancial burden of diabetes. Th e 
purpose of this article is to describe the development of the Diabetes Evaluation 
Framework (DEFINE), present an overview of the framework, and discuss its 
potential impact on diabetes prevention and management.
METHODS
A comprehensive search of published and grey literature was used to identify ex-
isting evaluation frameworks. A search of Pubmed for English-language literature 
published before January 31, 2012 using keywords performance, measurement, 
4 Paquette-Warren et al.
© 2014 CJPE 29.2, 1–20 doi: 10.3138/cjpe.29.2.1
surveillance, evaluation, framework, national, global, quality of primary health 
care, and diabetes was completed. We also conducted a review of grey literature 
published before January 31, 2012, focusing on government and health organiza-
tion websites. Articles and sources were considered relevant if they focused at the 
national level on system performance assessment and/or evaluation frameworks 
(countries that fi t this criteria included Australia, Canada, Denmark, Israel, Nor-
way, Republic Srpska of Bosnia and Herzegovina, the United Kingdom, and the 
United States). 
Th rough a series of fi ve face-to-face Advisory Council expert committee meet-
ings held between 2009 and 2012, draft s of the framework were presented to 
experts in diabetes, family medicine, policy, evaluation, medicine, and research. 
Each meeting included a presentation of the most recent iteration of DEFINE 
including defi nitions, conceptual theory, components, and a discussion period 
to refi ne and expand the draft  framework. Evaluation frameworks are political 
in nature; thus our overarching goal through this iterative process was to ensure 
that there were key stakeholder representation and sound methodological pro-
cesses, in hopes of moving forward with a usable, adaptable, and relevant diabetes 
evaluation framework capable of bringing about positive change in our healthcare 
system.
FINDINGS
Existing Diabetes Evaluation Frameworks
In search of existing evaluation frameworks, it became clear that surveillance 
systems, performance measurement strategies, and evaluation framework are terms 
that are being used interchangeably in the literature, particularly the grey litera-
ture. As noted by Bowen (2012), performance measurement is typically limited by 
the availability of quantitative outcome measure data and relies on simple designs 
that fail to assess the impact of infl uential factors inherent in complex systems 
such as healthcare. Evaluation research is broader and aimed at asking the hard 
questions about the causal relationships between programs and outcomes, using 
a variety of mixed methods (Blalock, 1999). Keeping in mind these defi nitions 
and misconceptions, below is a summary of results related to existing evaluation 
frameworks as described in the literature.
General health-related national system-level performance measurement and 
national evaluation frameworks exist and provide the wider context for disease-
specifi c frameworks to be tailored and positioned (Canadian Institute for Health 
Information, 2011a; Hogg, Rowan, Russell, Geneau, & Muldoon, 2008; McLough-
lin, Leatherman, Fletcher, & Owen, 2001; World Health Organization, 2010). 
Specifi c to diabetes, national surveillance systems, performance measurement 
frameworks, or national evaluation frameworks were identifi ed in Australia (e.g., 
National System for Monitoring Diabetes; Australian Institute of Health and Wel-
fare, 2011), Canada (e.g., National Diabetes Surveillance System [NDSS]; Public 
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Health Agency of Canada, 2009), Denmark (e.g., Th e National Indicator Project; 
Mainz, Krog, Bjornshave, & Bartels, 2004), Sweden (Th e Swedish National Diabe-
tes Register; Gudbjornsdottir, Cederholm, Nilsson, Eliasson, & Steering Commit-
tee of the Swedish National Diabetes Register, 2003), the United Kingdom (e.g., 
Diabetes National Service Framework, Quality and Outcomes Framework in the 
UK, National Diabetes Audit; National Health Service, 2007; National Health 
Service, 2012; National Institute for Health and Clinical Excellence, 2012), and 
the USA (e.g., National Quality Report, National Diabetes Education Program 
Evaluation Framework, Diabetes Quality Improvement Project; Fleming et al., 
2001; Gallivan, Greenberg, and Brown, 2008).
Th e current strategies to assess diabetes care and outcomes described in the 
literature are focused on capturing clinical data with an emphasis on surveil-
lance and building electronic infrastructure in the healthcare system (Khan, 
Mincemoyer, & Gabbay, 2009). Th e challenges related to the availability of high-
quality data to assess diabetes care remain, and they are typically related to the 
need to balance rigour, cost, and feasibility of obtaining administrative versus 
self-reported versus chart audit data. Some countries have clearly articulated na-
tional targets, but the processes for measurement are poorly developed; in other 
countries, the processes for data gathering are well established, but the quality 
of the data is not reliable. Furthermore, the search for a set of indicators that 
are meaningful at a national level for the purpose of improvement in diabetes 
prevention and management continues. Building on existing frameworks are the 
Organization for Economic Co-operation and Development (OECD) Healthcare 
Quality Indicators Project for Diabetes for an overarching system for global sur-
veillance (Kelley, Arispe, & Holmes, 2006; OECD, 2011) and the International 
Diabetes Federation (2013). Th ese are important to help identify key diabetes 
indicators for surveillance, but they do not encompass indicators related to the 
system or environment (e.g., continuum of care, care utilization, resource utiliza-
tion) that play an important role in diabetes prevention and management and are 
critical to informing stakeholders about system performance and improvement 
nationally, regionally, or locally (Chaudoir, Dugan, & Barr, 2013). As indicated by 
Blalock (1999), because of the limited scope of surveillance data and performance 
measures, performance monitoring alone does not provide enough information 
to make trustworthy inferences about the impact of programs on outcomes.
In Canada, the focus has been on building an infrastructure through the 
NDSS for high-quality surveillance data using administrative data to help with 
planning of eff ective policies and initiatives (Khan et al., 2009; Public Health 
Agency of Canada, 2011a). Many provinces and territories have contributed to 
NDSS and built on it with their own strategies to expand surveillance of their dia-
betes population and care utilization. Th e data are collected retrospectively, mak-
ing them useful for a variety of important epidemiologic studies that are relevant 
to clinical management, but retrospective data limit opportunities for impact on 
improving quality care (Khan et al., 2009). Th e Health Indicators Framework of 
the Canadian Institute for Health Information (CIHI) for system performance 
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includes numerous levels and dimensions to help identify critical multilevel 
indicators related to chronic care and quality of care, but it does not emphasize 
the relationships between the levels or the causal linkages between programs and 
outcomes (Canadian Institute for Health Information, 2011b). Likewise, a concep-
tual framework for primary care has been developed to consider structural and 
organizational features that impact performance, but it doesn’t take into account 
the entire system (Hogg et al., 2008). In summary, the current Canadian perfor-
mance measurement and conceptual frameworks, as well as the diabetes surveil-
lance system, provide a great foundation to build on. However, there needs to be 
more focus on linking investments or program activities to outcomes, and clearer 
applicability and utility by acknowledging the important role of stakeholders in 
determining relevant and meaningful evaluation goals, designs, and knowledge 
translation activities specifi c to diabetes.
The Diabetes Evaluation Framework (DEFINE)
To move beyond surveillance and performance measurement alone, DEFINE 
has three main goals: (a) to guide the comprehensive and systematic evaluation 
of initiatives, programs, and models that aim to improve diabetes prevention and 
management; (b) to build a robust body of evidence regarding health outcomes, 
quality of care, and the impact of these initiatives on patients with diabetes; and 
(c) to outline knowledge translation to inform stakeholders as they refi ne poli-
cies and fund initiatives to help address the increasing prevalence of diabetes and 
associated costs (Figure 1). Th e scope of DEFINE is broad and system-focused, 
covering the organization of healthcare; healthcare delivery; environmental (non-
medical) factors; and the patient; and includes prevention, identifi cation, and 
management of diabetes and associated complications (Figure 2). Embedded 
within the framework are key performance indicators that are inclusive of, but not 
limited to, clinical processes and outcomes. Furthermore, the framework encap-
sulates the six dimensions of quality—safety, effi  ciency, eff ectiveness, accessibility/
timeliness, responsiveness/patient-centredness, and equity (World Health Organ-
ization, 2006)—and builds on the concepts embedded in the Chronic Care Model 
(Wagner, et al., 2001), the Expanded Chronic Care Model (Barr et al., 2003), the 
Ontario Chronic Disease Prevention and Management Framework (Ministry 
of Health and Long-Term Care, 2007), and the Health Indicators Framework 
(Canadian Institute for Health Information, 2011a). To reach its goals, DEFINE 
includes fi ve steps: (a) work with stakeholders to identify evaluation goals, (b) 
select multilevel indicators and associated measurement tools, (c) synthesize the 
knowledge, (d) develop a dissemination plan with stakeholders, and (e) partici-
pate in knowledge exchange.
Th e comprehensive design and inclusive nature of DEFINE and its built-in 
fl exibility allow for its application irrespective of the type of diabetes initiative or 
research question of interest because it permits users to determine and select the 
most appropriate indicators, tools, and methodologies for their respective con-
text and evaluation goals. As such, DEFINE is well positioned to (a) facilitate the 
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Figure 1. Schematic of the Diabetes Evaluation Framework (DEFINE)
identifi cation of care gaps, (b) enhance transparency and inclusive decision mak-
ing for greater accountability, (c) encourage examination of policy and economic 
implications, and (d) provide direction for future funding/program planning 
related to diabetes care and associated complications. Overcoming the limita-
tions of existing frameworks, the systematic approach of DEFINE with multilevel 
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Figure 2. High-level Multilevel Indicator Schematic
common indicators promotes the capture of relevant and meaningful standards/
benchmarks of diabetes care across the healthcare system and environmental con-
text, and will greatly inform key stakeholders as they continue to strive to improve 
diabetes prevention and management in Canada. Below is a brief description of 
each component of the framework.
A. Guide Comprehensive Evaluation
Th e fi rst step in applying the framework (Step 1) is to work with relevant stake-
holders (e.g., program planners and implementers, decision-makers, experts, 
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participants, recipients) to identify evaluation goals that will ensure the selection 
of methodologies and measures yielding results that are relevant and applicable 
in terms of assessing impact and bringing about positive change (Bowen, 2012; 
Bryson, Patton, & Bowman, 2011; Craig et al., 2013; Creswell & Plano Clark, 2011; 
Dubois et al., 2011; Song, Sandelowski, & Happ, 2010).
A complete picture of the healthcare system and environmental context is 
required to understand the multitude of mechanisms and processes underlying 
care and patient health (Dubois et al., 2011; Hulscher, Laurant, & Grol, 2003). 
Th erefore, a comprehensive (implementation/process and outcomes/summative) 
evaluation approach is necessary to examine not only the outcomes of interest, but 
also the interactions and causal linkages between the intervention/program and 
the outcomes (Blalock, 1999; Chen, 2005; Crabtree et al., 2011; Creswell & Plano 
Clark, 2011; Dehar, Casswell, & Duignan, 1993; Petrosino, 2000; Rush & Ogborne, 
1991; Vingilis & Pederson, 2001). Th e involvement of relevant stakeholders in 
developing a logic model is critical to outlining mechanisms existing at multilevels 
of the healthcare system, the environment, and the patient that may be responsible 
for the results (Chen, 2005; Dubois et al., 2011; Gallivan et al., 2008; Hulscher et 
al., 2003; Zimmerman et al., 2011). Also, the logic model can highlight the value 
of evidence to stakeholders, help determine the most appropriate research design 
and analyses, and facilitate the selection of appropriate multilevel indicators 
(Chen, 2005; Craig et al., 2013; Dubois et al., 2011; McEwan & Bigelow, 1996).
B. Build a Balanced and Robust Body of Evidence: Components of DEFINE
As highlighted in Step 1, comprehensive evaluations incorporating multilevel 
indicators are critical. DEFINE includes four levels with multiple components 
(Figure 2): (a) Organization of Healthcare; (b) Healthcare Delivery (practice-based 
care, community-based care, hospital-based care); (c) Environment; and (d) Patient. 
Using the logic model developed in Step 1, Step 2 involves the careful selection of 
multilevel indicators and measurement tools to understand the implementation 
process, to measure outcomes that are relevant and applicable, and to discover the 
interactions and causal linkages between the initiative and outcomes. It is critical to 
capture data across all levels to have adequate information to assess the degree of 
success of initiatives (i.e., fi delity and quality of implementation, causal mechanisms, 
intended outcomes, unintended consequences, and contextual factors; Craig et al., 
2013). Where possible, follow-up for interim or surrogate measures should be con-
sidered to assess sustainability and optimization (Craig et al., 2013).
Organization of Healthcare Level
Th e organization of healthcare level encompasses health policy grounded by the 
pillars, dimensions, and rights of quality (World Health Organization, 2006). Th is 
level includes indicators related to existing organizational and funding struc-
tures, fi scal measures, reform strategies, taxation, and local/regional/provincial/
national support structures such as clinical practice guidelines. It is characterized 
by (a) leadership commitment to a chronic disease management approach and 
improved quality of services; (b) the existence of necessary resources such as 
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physical space, staffi  ng and medical supplies; (c) accountability; and (d) a com-
mitment to sustainability and spread of successful initiatives/strategies.
Healthcare Delivery Level
Directly shaped by the underpinning organization of healthcare are the three 
locales of healthcare delivery (practice-based care, hospital-based care, and 
community-based care) that each off er a unique and vital support structure for 
patients related to care utilization, care delivery, and care support. Th e circular 
nature of care delivery, indicated by the arrows between the locales of care in 
Figure 2, suggests that using only one part of the system is insuffi  cient to obtain 
and maintain overall health and wellness. To improve chronic disease prevention/
management and successfully infl uence diabetes prevention, management, and 
clinical outcomes, one must recognize the integrated nature of the locales (World 
Health Organization, 2006). In DEFINE, the locales are bound by the organization 
of healthcare and by the mechanisms of care delivery that take into consideration 
the four aspects of the chronic care model: self-management support, delivery sys-
tem design, decision support, and information systems (Barr et al., 2003; Ministry 
of Health and Long-Term Care, 2007; Wagner et al., 2001).
I. SELF-MANAGEMENT SUPPORT
Th is component of healthcare delivery is oriented to the role of healthcare provid-
ers in enhancing patients’ knowledge, skills, and involvement in their own care. 
Th is includes a structured adoption and use of a patient-centred approach, self-
management measures and indicators including health behaviours, quality of life, 
collaborative care, problem solving and goal setting, shared decision making, and 
appropriate use of resources.
II. DELIVERY SYSTEM DESIGN
Delivery system design is oriented to maintaining or restoring the health of indi-
viduals and groups, and incorporates changes to the organization of practice (e.g., 
patient fl ow) that impact the provision of accessible and safe care and encourage 
productive patient interactions. For example, it includes better organization of 
health information and its timely availability, a reduction in duplication of ser-
vices, and better healthcare planning. Furthermore, it encompasses adherence 
to evidence-based practice guidelines, principles related to patient-centred care, 
proactive care/planned visits, and population-level health promotion/disease 
prevention/disease detection. Lastly, this component includes enhanced team 
structure and function for service alignment/coordination, ease of patient naviga-
tion, continuity of care, and more commitment to quality improvement and to the 
establishment of partnerships with community members and other stakeholders 
to enable and empower patients and advocate for healthy public policy.
III. PROVIDER DECISION SUPPORT
Provider decision support is oriented to improving the knowledge and skills of 
providers and administrators. It includes embedding evidence-based guidelines 
(Canadian Diabetes Association Clinical Practice Guidelines Expert Committee, 
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2013) into daily practice, enhancing the relationships among providers and ad-
ministrators from diff erent locales of care, and using clinical care and client man-
agement tools (e.g., fl ow sheets, registry, and patient assessment/disease severity 
tools) that link indicators with recommendations for treatment or health behav-
iour change strategies. Also, it comprises routine feedback reports (mechanisms) 
regarding measurements, evaluation, and performance.
IV. CLINICAL INFORMATION SYSTEMS
Th e clinical information systems component is oriented to tracking, measur-
ing, evaluating, and sharing health information to provide timely, accurate, and 
comprehensive information about individual patients or groups of patients. Th is 
is characterized by the tracking of population-level data, the existence of patient 
registries, and the advanced use of EMRs (e.g., patient tracking, embedded CPGs/
system reminders, severity indicators with recommendations for treatment, and 
performance feedback), all leading to better access to health information for pro-
active and coordinated care and improved collaborative treatment plans.
Environment Level
Building on the importance of the environment as a determinant of health and a 
key component in the Expanded Chronic Care Model (Barr et al., 2003), DEFINE 
extends beyond the traditional healthcare system to focus on the important role 
of prepared and proactive community partners, as well as informed and activated 
communities. Communities are included for the role they play in the manage-
ment of the nonmedical determinants of health including socioeconomic, living, 
and working conditions, as well as the political and physical environment. Th is 
level has three components: (a) Supportive Political and Physical Environment, 
(b) Community Action, and (c) Public Policy. Th e linkages between the multilevel 
healthcare system and the broader environment play an important role in the 
management of chronic illness to promote health and prevent chronic diseases 
such as diabetes (Public Health Agency of Canada, 2011a).
I. SUPPORTIVE PHYSICAL AND POLITICAL ENVIRONMENT
Integral to a supportive physical and political environment is the political/
leadership commitment to establishing healthy and equitable socioeconomic, liv-
ing, and working conditions and the existence of accessible systems or structures 
(e.g., housing, transportation, justice, employment) that are stable, secure, safe, 
and patient-centred (i.e., stimulating, satisfying, and enjoyable). Th is component 
includes the effi  cient use of systems or structures that are cost-eff ective and the 
existence of relationships/partnerships among structures for continuity of care 
related to patient transitions from one healthcare provider to the next or from one 
locale of care to another (e.g., linkages among community members/stakeholders 
and leaders/providers in healthcare).
II. COMMUNITY ACTION
Th is component encompasses the community’s role in being knowledgeable about 
and responsible for the identifi cation of risk behaviours and environmental (living 
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and working) conditions that impact community members’ health. It includes a 
community’s mobilization and public participation in activities to manage non-
medical factors that infl uence health. A critical element in this component is the 
existence of relationships/partnerships among community members/stakeholders 
(e.g., municipalities, advocacy groups, recreation centres, service clubs) and lead-
ers/providers in healthcare, research, education, and other relevant realms to 
identify patient needs and build adequate knowledge and skills.
III. PUBLIC POLICY
Th e existence of organizational and governmental policies and legislation that 
foster greater equity related to safer and healthier goods, services, and environ-
ments (e.g., dietary guidelines, reduced pricing for whole-wheat products and 
fruits) is the basis of this component. It captures the community advocacy ef-
forts to develop new organizational and governmental policies and legislation in 
non-healthcare areas (housing, transportation and food distribution, education, 
justice, employment) that may enhance the health of the community.
Patient Level
At the centre of DEFINE is the patient as an informed and active partner (enabled 
and empowered) in the management of medical and nonmedical determinants of 
health including health status, health condition, health function, human biology, 
health behaviours and lifestyle, and personal resources (e.g., education, literacy, 
skills, confi dence in self-management, social support, culture, income, employ-
ment, social status, coping skills). Patients play an important role in (a) recogniz-
ing their own health status; (b) making appropriate use of services; (c) working 
with their care team to establish an appropriate treatment plan by identifying 
personal barriers, challenges, and preferences; (d) adhering to treatment plans 
by attending planned visits/referral appointments/scheduled tests and/or taking 
medications; (e) participating in educational activities; and (f) making appropri-
ate use of community structures and other support systems. Th is level is charac-
terized by patient satisfaction with accessibility, eff ectiveness, patient-centredness, 
interaction with their care team, living conditions, treatment plan, community 
action, community structures and systems, and public policies.
C. Knowledge Translation to Inform Stakeholders
Th e third goal of DEFINE is to inform stakeholders through knowledge translation 
and exchange activities that link results to policy issues and guide policy devel-
opment. Knowledge translation is “a dynamic and iterative process that includes 
synthesis, dissemination, exchange and ethically sound application of knowledge 
to improve the health of Canadians, provide more eff ective health services and 
products, and strengthen the healthcare system” (Canadian Institutes of Health 
Research, 2010, p. 2). To accomplish this goal, Step 3 involves knowledge synthesis 
to integrate individual research fi ndings through scientifi cally sound synthesis 
methods including meta-analysis, systematic reviews, Cochrane reviews, realist 
synthesis, narrative synthesis, and results from a consensus conference or expert 
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panel (Canadian Institutes of Health Research, 2010). Step 4 is to develop a dis-
semination activity plan in collaboration with stakeholders (e.g., communities, 
providers, patients, and policy experts). Th e goal of all dissemination and knowl-
edge translation materials is to identify key messages for diff erent target audiences 
(e.g., government and organizational leaders, policy experts, diabetes researchers, 
clinician scientists, and end-users such as community stakeholders and patients) 
and to tailor the language and medium used in dissemination materials to be eas-
ily assimilated by the diff erent audiences. Finally, Step 5 includes both integrated 
and program-end knowledge translation to align the knowledge to action cycle 
(Straus & Holroyd-Leduc, 2008). Its goal is to develop policy briefs and recom-
mendations with policy partners in a way that overcomes barriers to knowledge 
translation and ensures the topics and content are relevant to policy (Grimshaw, 
Eccles, Lavis, Hill, & Squires, 2012). Program-end meetings are an optimal ap-
proach to bringing together all key stakeholders for the exchange of evaluation 
results and experiences. Finally, but only aft er internal dissemination activities, 
external dissemination can include scholarly publications and conference pres-
entations, with or without media engagement, that can facilitate exchange eff orts 
between researchers and the end users of the research. Knowledge translation is 
essential to meeting the overall objective of the DEFINE framework: ensuring 
ethically sound application of knowledge to improve the healthcare system for 
better diabetes care and outcomes and to contribute to decreasing the burden of 
diabetes.
DISCUSSION
With the increasing pandemic of diabetes and its associated healthcare costs, 
substantial investments to implement initiatives and refi ne policies have been 
made by key stakeholders as they continue to strive to improve diabetes preven-
tion and management and reduce the burden of diabetes in Canada. Th erefore, a 
major research focus should be placed on evaluation of strategies and initiatives 
to determine their utility and benefi ts. Conducting comprehensive and systematic 
evaluations will increase our understanding of initiatives, programs, or models 
and determine which investments in healthcare should be continued or redi-
rected, and where new investments are needed.
DEFINE was designed to guide the evaluation of diabetes prevention and 
management; however, it can be employed to evaluate a variety of chronic ill-
nesses with appropriate adaptation. DEFINE will help to determine if organiza-
tions, programs, quality improvement initiatives, and other interventions have 
resulted in better process or clinical outcomes, healthier patients, more satisfi ed 
providers, and more cost-eff ective expenditure of healthcare and community 
resources. Specifi cally, DEFINE is designed to consider all aspects of the health 
systems across the continuum of care, the relationship among the locales of care 
delivery, and the linkages among the patient, the healthcare system, and the broad 
environmental context. Given the current patterns of ongoing healthcare reform, 
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a cultural shift  is required and the broad system focus of DEFINE uniquely 
ensures outcome-oriented health policy and serves as a guide for program plan-
ning and evaluation.
DEFINE is inclusive yet fl exible in its application, and the various compo-
nents of DEFINE may be relevant to some research questions but not others. 
Inclusivity fosters comprehensiveness, and fl exibility inspires innovation to de-
termine the set of indicators that are most likely to be eff ective in demonstrating 
improved performance and identifying opportunities for improvement. Th ere-
fore, as the framework is applied and the body of research builds, so will this 
framework. Because DEFINE builds on the evidence in the fi eld of diabetes sur-
veillance, performance measurement, and existing evaluation frameworks, as well 
as general health and chronic disease models and frameworks, it carries forward 
lessons-learned and synthesizes this information to position this framework as a 
standardized tool for diabetes.
As discussed throughout this article, comprehensive evaluation of diabetes 
care (prevention and management) is a necessary fi rst step toward building an 
evidence base to inform and enable policy makers, government, and other stake-
holders with suffi  cient information to make accountable decisions about our 
healthcare (Borgermans et al., 2008). In a time of resource spending constraints, 
public demand for more accountability, and insuffi  cient number of healthcare 
providers to manage the growing population of patients with diabetes, fostering 
an evidence base for policy makers grounded in a conceptual framework assists in 
the prioritization of healthcare initiatives, and plays an integral role in the design, 
management and provision of healthcare services (Garcia-Altes, Zonco, Borrell, 
Plasencia, & Barcelona Group on the Performance of Health Care Services, 2006; 
Garcia-Altes et al., 2007).
Reported here is the fi rst step in creating a national diabetes evaluation 
strategy that is appropriate and fl exible enough to be applied by diff erent users 
and in diff erent settings. Th is framework will help to build the necessary informa-
tion and capacity to raise the quality of diabetes care in Canada and to prevent 
and delay diabetes and related complications. Next steps in the development of 
DEFINE will include (a) a Modifi ed Delphi process to assess the construct and 
content validity of the conceptual basis of DEFINE and its embedded indicators 
and related measurement tools, (b) an assessment of the utility and feasibility of 
DEFINE through a retrospective case study of an initiative that targeted diabetes 
prevention and management in Canada, and (c) the application of DEFINE in a 
prospective case study.
CONCLUDING THOUGHTS
In the midst of the diabetes pandemic and escalating healthcare costs, DEFINE 
is well positioned to facilitate the identifi cation of care gaps, guide needs assess-
ments and quality improvement initiatives, and ultimately provide direction for 
future funding and program planning related to diabetes care and associated com-
plications. Th e ultimate goal of DEFINE is to support the enhancement of diabetes 
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care as a model for chronic disease with greater functionality and accountability 
in Canada’s healthcare system.
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